Edgestream Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Sell	34,055 -92,296	-73%	-$5.38M	0.06%	499
2025 Q4	$7.51M	Sell	126,351 -71,678	-36%	-$3.9M	0.21%	133
2025 Q3	$10.7M	Buy	198,029 +68,469	+53%	+$3.92M	0.31%	56
2025 Q2	$7.12M	Buy	129,560 +68,928	+114%	+$4.06M	0.2%	186
2025 Q1	$4.29M	Sell	60,632 -84,364	-58%	-$5.68M	0.15%	275
2024 Q4	$9.53M	Buy	144,996 +116,434	+408%	+$7.8M	0.41%	16
2024 Q3	$2.01M	Buy	+28,562	New	+$2.39M	0.09%	401
2024 Q2	–	Sell	-19,678	Closed	-$1.72M	–	858
2024 Q1	$1.72M	Buy	+19,678	New	+$1.76M	0.09%	369
2023 Q3	–	Sell	-9,180	Closed	-$796K	–	822
2023 Q2	$796K	Sell	9,180 -3,429	-27%	-$323K	0.07%	409
2023 Q1	$1.23M	Buy	+12,609	New	+$1.31M	0.14%	246
2022 Q4	–	Sell	-3,026	Closed	-$257K	–	512
2022 Q3	$257K	Sell	3,026 -1,560	-34%	-$139K	0.02%	411
2022 Q2	$380K	Sell	4,586 -12,115	-73%	-$965K	0.03%	433
2022 Q1	$1.29M	Buy	+16,701	New	+$1.4M	0.1%	287